Abiopharma

Chiron Real Estate Inc. Announces $100 Million Strategic Convertible Perpetual Preferred Equity Investment Led by Maewyn Capital Partners

Chiron Real Estate Inc. Enters into Agreements to Acquire $425 Million of SHOP Communities

Q1 2026 Financial Results

LifeVantage Declares Quarterly Dividend

KORU Medical Systems Announces First Quarter 2026 Results

Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026

Alto Ingredients, Inc. Reports First Quarter 2026 Results

Vir Biotechnology - Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results

agilon health - agilon health Reports First Quarter 2026 Results

Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update